Author:
Wang Hua,Xu Zhi,Chen Dandan,Li Huihui,Zhang Junyan,Liu Qinghuai,Shen Han
Abstract
AbstractThis cross-sectional study aims to investigate the prevalence and causes of visual impairment (VI) and blindness in Jiangsu Province, China in 2022 during the COVID-19 pandemic. Participants (n = 13,208, aged 18–93) underwent comprehensive ocular examinations. The prevalence and causes of binocular VI (presenting visual acuity [VA] ≥ 20/400 and < 20/63 in the better eye) and blindness (presenting VA < 20/400 in the better eye) were assessed according to the World Health Organization (WHO) criteria. The estimation of refractive error prevalence was conducted using the following classification: myopia ≤ − 0.50 diopters (D), high myopia ≤ − 6.00 D, hyperopia ≥ 0.50 D, and anisometropia ≥ 1.00 D. The overall prevalence of binocular VI and blindness was 21.04% (95% confidence interval [CI] 20.35–21.74%) and 0.47% (95% CI 0.37–0.60%). The highest prevalence of binocular VI was in the population aged 18–24 years old (46.29%, [95% CI 44.30–48.28%]), those with education at university and above (43.47%, [95% CI 41.93–45.02%]), students (54.96%, [95% CI 52.73–57.17%]). Uncorrected refractive error (URE) was the leading cause of presenting binocular VI (93.40%) and blindness (50.79%). The prevalence of myopia was 54.75% (95% CI 53.90–55.60%). Actions are needed to control URE and myopia within the adult Chinese population, with a particular emphasis on the younger, well-educated demographic.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Jiangsu Province
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 395, 497–506 (2020).
2. Shalaby, W. et al. The impact of COVID-19 on individuals across the spectrum of visual impairment. Am. J. Ophthalmol. 227, 53–65 (2021).
3. Ciotti, M. et al. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 57, 365–388 (2020).
4. Sachs, J. et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet (London, England). 400, 1224–1280 (2022).
5. General Office of the National Health Commission. The Notice on Issuing Guidelines for Home Isolation and Medical Observation for the Prevention and Control of Novel Coronavirus Infection (Trial) by the General Office of the National Health Commission. Available at, https://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474688.htm (2020).